TrialCancer research communications2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent
Kristina Fanucci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papertrialcites it
TrialCancer research communications2023
Kristina Fanucci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.